Efforts to decriminalise psilocybin, more commonly known as magic mushrooms, are gathering momentum in the United States.
The cities of Denver, Oakland and Santa Cruz have already decriminalised the psychedelic drug. Washington DC is soon expected to vote on whether to follow suit. And the state of Oregon is set to hold a poll on full legalisation.
The push is in part led by medical researchers who are finding growing evidence that the substance can effectively treat mental health conditions such as depression and PTSD.
In fact, the Food and Drug Administration (FDA) has fast-tracked research on psilocybin
as a treatment for PTSD, calling it a potential breakthrough therapy.
Young tech entrepreneurs are also leading a charge towards mainstream acceptance, claiming that microdosing (taking psilocybin daily in very small amounts) can boost productivity and leadership skills.
In this episode of The Stream we ask, what evidence is there to support these claims and could magic mushrooms one day become as common in bathroom cupboards as vitamins?
On this episode of The Stream, we speak with:
Danielle Herrera
Harm Reduction and Psychedelic Psychotherapist
sageinst.org
Ismail Ali, @sage_izzy
Policy and Advocacy Counsel, @MAPS
maps.org
Michelle Janikian, @m00shian
Journalist
michellejanikian.com
Join the conversation:
TWITTER: https://twitter.com/AJStream
FACEBOOK: http://www.facebook.com/AJStream
Subscribe to our channel http://bit.ly/AJSubscribe
#aljazeeraenglish
#ajstream
#psilocybin
source